Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China’s Global Pharma Supply Chain Operations Resuming In Wake Of Outbreak, USP Says

Executive Summary

USP reference standard sales showed slow resumption of API manufacturing in China and less-than-expected API use in India.

You may also be interested in...



USP Map Charts Way To Medicine Supply Resiliency

Supply chain project shows which drug products are at greatest risk in different scenarios – and which responses would do the most to prevent shortages. Officials from the pharmacopoeial group share how it works and what it can do to help bake in resilience against pandemics, natural disasters, trade wars and shooting wars.

USP Building Risk Model To Assess Supply Chain Vulnerabilities And Anticipate Drug Shortages

The USP is developing a risk model to assess whether pharmaceutical supply chains are strong or weak based on demand for reference standards.

BARDA Begins Stockpiling APIs For Critical Drugs

US agency ensures pharmaceutical companies could manufacture critical medicines domestically even if cut off from China's API suppliers, while stockpiling pandemic medicines during pandemic with Baxter, Fresenius contracts.

Related Content

Topics

UsernamePublicRestriction

Register

PS141845

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel